Histological analysis revealed that, compared to monotherapies with Vin, anti-PD-1, or rIL-24, the combination treatments significantly reduced Ki67 expression, indicating more efficient inhibition of tumor proliferation (Fig. 6F-G). Here, MKI67 is linked to neoplasm.